肝细胞癌疼痛：影响及管理挑战
Hepatocellular cancer pain: impact and management challenges.
作者信息
Christian-Miller Nathaniel, Frenette Catherine
机构信息
Scripps Clinical Research, Scripps, San Diego, CA, USA.
Scripps Center for Organ and Cell Transplantation, Scripps Green Hospital, La Jolla, CA, USA,
出版信息
J Hepatocell Carcinoma. 2018 Jul 19;5:75-80. doi: 10.2147/JHC.S145450. eCollection 2018.
Abstract
Hepatocellular carcinoma (HCC) remains the most common primary liver malignancy. Pain comprises one of the most pervasive and troubling symptoms of HCC and may have severely negative effects on patient's quality of life. Furthermore, because HCC frequently arises in the setting of cirrhosis, treating pain related to this malignancy poses a clinical challenge. This article summarizes manifestations of hepatocellular cancer pain, common obstacles to treatment, and practical HCC pain management.
摘要
肝细胞癌（HCC）仍然是最常见的原发性肝脏恶性肿瘤。疼痛是HCC最普遍且令人困扰的症状之一，可能会对患者的生活质量产生严重负面影响。此外，由于HCC常发生于肝硬化背景下，治疗与这种恶性肿瘤相关的疼痛带来了临床挑战。本文总结了肝细胞癌疼痛的表现、治疗的常见障碍以及实用的HCC疼痛管理方法。
相似文献
1
Hepatocellular cancer pain: impact and management challenges.肝细胞癌疼痛：影响及管理挑战
J Hepatocell Carcinoma. 2018 Jul 19;5:75-80. doi: 10.2147/JHC.S145450. eCollection 2018.
2
Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist.肝细胞癌：病理学家面临的诊断挑战综述
J Hepatocell Carcinoma. 2018 Nov 8;5:99-108. doi: 10.2147/JHC.S159808. eCollection 2018.
3
Challenges of advanced hepatocellular carcinoma.晚期肝细胞癌的挑战
World J Gastroenterol. 2016 Sep 14;22(34):7645-59. doi: 10.3748/wjg.v22.i34.7645.
4
Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review.无肝硬化的肝细胞癌伴高钙血症：病例报告及文献综述
J Clin Exp Hepatol. 2015 Jun;5(2):163-6. doi: 10.1016/j.jceh.2015.04.001. Epub 2015 Apr 18.
5
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.非肝硬化非酒精性脂肪性肝病（NAFLD）患者肝细胞癌（HCC）的特征
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.
6
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.等待肝移植的肝细胞癌患者的局部区域治疗：选择最佳治疗方法。
World J Transplant. 2016 Jun 24;6(2):306-13. doi: 10.5500/wjt.v6.i2.306.
7
Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.高敏C反应蛋白检测对乙型肝炎相关性肝硬化患者肝细胞癌诊断的评估
Oncol Lett. 2017 May;13(5):3457-3464. doi: 10.3892/ol.2017.5890. Epub 2017 Mar 22.
8
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.口服羟考酮/纳洛酮治疗肝硬化疼痛：伴有症状转移性肝细胞癌患者的观察性研究。
Liver Int. 2018 Feb;38(2):278-284. doi: 10.1111/liv.13546. Epub 2017 Sep 4.
9
Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies.肝移植前肝细胞癌的肝脏靶向治疗：当代管理策略
Glob Surg. 2018 Apr;4(1). doi: 10.15761/GOS.1000171. Epub 2018 Feb 15.
10
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.从肝癌的诊断到治疗：发达国家和发展中国家共同面临的流行问题。
World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282.
引用本文的文献
1
Meta-analysis of multimodal analgesia for reducing postoperative wound pain after hepatectomy for hepatocellular carcinoma.多模式镇痛用于减轻肝细胞癌肝切除术后伤口疼痛的Meta分析
Sci Rep. 2025 May 3;15(1):15494. doi: 10.1038/s41598-025-00069-4.
2
A Randomized, Double-Blind, Placebo-Controlled Trial Protocol Using the Fuzhengxiaoliu Patch for the Management of Primary Liver Cancer Pain.一项使用扶正消瘤贴治疗原发性肝癌疼痛的随机、双盲、安慰剂对照试验方案
J Pain Res. 2025 Jan 6;18:33-42. doi: 10.2147/JPR.S500305. eCollection 2025.
3
Construction of Pain Management Strategies After Hepatectomy: Evidence Summary and Delphi Study.肝切除术后疼痛管理策略的构建：证据总结与德尔菲研究
J Pain Res. 2024 Dec 27;17:4541-4559. doi: 10.2147/JPR.S494243. eCollection 2024.
4
Treatment of Moderate-to-Severe Pain in Hepatocellular Carcinoma with Transcutaneous Electrical Acupoint Stimulation: A Randomized Controlled Trial.经皮穴位电刺激治疗肝细胞癌中重度疼痛：一项随机对照试验
J Pain Res. 2024 Apr 29;17:1583-1594. doi: 10.2147/JPR.S456874. eCollection 2024.
5
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.《2022年韩国肝脏癌协会-韩国国立癌症中心肝细胞癌管理实践指南》
J Liver Cancer. 2023 Mar;23(1):1-120. doi: 10.17998/jlc.2022.11.07. Epub 2022 Dec 9.
6
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.2022KLCA-NCC 韩国肝细胞癌管理实践指南。
Korean J Radiol. 2022 Dec;23(12):1126-1240. doi: 10.3348/kjr.2022.0822.
7
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.2022 KLCA-NCC 韩国肝细胞癌管理实践指南。
Clin Mol Hepatol. 2022 Oct;28(4):583-705. doi: 10.3350/cmh.2022.0294. Epub 2022 Oct 1.
8
Transcutaneous Electrical Acupoint Stimulation for Moderate to Severe Pain in Hepatocellular Carcinoma: A Protocol for a Randomized Controlled Trial.经皮穴位电刺激治疗肝细胞癌中重度疼痛：一项随机对照试验方案
J Pain Res. 2022 Jul 6;15:1889-1896. doi: 10.2147/JPR.S361821. eCollection 2022.
9
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.美国癌症免疫治疗学会（SITC）肝癌治疗免疫治疗临床实践指南。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002794.
10
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma.钇-90 放射性栓塞桥接或降期治疗肝细胞癌患者的成功预测因素。
Can J Gastroenterol Hepatol. 2021 Jul 22;2021:9926704. doi: 10.1155/2021/9926704. eCollection 2021.
本文引用的文献
1
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
2
Clinical analysis of electroacupuncture and multiple acupoint stimulation in relieving cancer pain in patients with advanced hepatocellular carcinoma.电针联合多穴位刺激缓解晚期肝细胞癌患者癌痛的临床分析
J Cancer Res Ther. 2018 Jan;14(1):99-102. doi: 10.4103/jcrt.JCRT_736_17.
3
Recent advances in understanding and managing cancer pain.癌症疼痛理解与管理的最新进展
F1000Res. 2017 Jun 20;6:945. doi: 10.12688/f1000research.10817.1. eCollection 2017.
4
Effect of Transcranial Direct Current Stimulation of the Motor Cortex on Visceral Pain in Patients with Hepatocellular Carcinoma.经颅直流电刺激运动皮层对肝癌患者内脏痛的影响。
Pain Med. 2018 Mar 1;19(3):550-560. doi: 10.1093/pm/pnx087.
5
Treatment of Patients with Cirrhosis.肝硬化患者的治疗
N Engl J Med. 2016 Nov 24;375(21):2104-5. doi: 10.1056/NEJMc1612334.
6
Risks factors for severe pain after selective liver transarterial chemoembolization.选择性肝动脉化疗栓塞术后严重疼痛的危险因素。
Liver Int. 2017 Apr;37(4):583-591. doi: 10.1111/liv.13235. Epub 2016 Sep 2.
7
Opioid Drugs in Patients With Liver Disease: A Systematic Review.肝病患者中的阿片类药物：一项系统评价
Hepat Mon. 2016 Mar 6;16(4):e32636. doi: 10.5812/hepatmon.32636. eCollection 2016 Apr.
8
Hepatocellular carcinoma: A comprehensive review.肝细胞癌：全面综述。
World J Hepatol. 2015 Nov 18;7(26):2648-63. doi: 10.4254/wjh.v7.i26.2648.
9
Role of supportive care for terminal stage hepatocellular carcinoma.支持性护理在晚期肝细胞癌中的作用。
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S130-9. doi: 10.1016/j.jceh.2014.03.049. Epub 2014 Mar 31.
10
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.放射治疗在肝细胞癌管理中的作用：一项系统综述。
World J Hepatol. 2015 Jan 27;7(1):101-12. doi: 10.4254/wjh.v7.i1.101.
Zotero 插件